Acta Scientific Microbiology

Research ArticleVolume 1 Issue 5

Double Speed Transfusion in Burkina Faso: Results of the Elisa 4th Generation Tests Versus Determine™ HIV½ of Blood Donors Presumed to be Seroconverting at National Blood Transfusion Center

Mahamoudou Sanou1,2*, Absétou Ky/Ba1, Delwindé Albert Komi1, Marius Nagalo6, Fidèle Bakiono5, Cyrille Bisseye7, Abdoul Salam Ouédraogo3, Ramata Ouédraogo1,2 and Jacques Simporé

1 University Ouaga I Pr Joseph KI-ZERBO, Ouagadougou, Burkina Faso
2 Pediatric University Hospital Charles De Gaulle, Ouagadougou, Burkina Faso
3 University Hospital Souro-Sanou, Bobo-Dioulasso, Burkina Faso
4 Pietro Annigoni Biomolecular Research Center (CERBA), Department of Biochemistry-Microbiology, University of Ouaga I Prof Joseph Ki Zerbo, Burkina Faso
5 Armed Forces Health Service, Ouagadougou, Burkina Faso
6 Department of Hematology/Oncology, Mayo Clinic Scottsdale, AZ, USA
7 Laboratory of Cellular and Molecular Biology, University of Franceville, Franceville, Gabon

*Corresponding Author: Mahamoudou Sanou, University Ouaga I Pr Joseph KI-ZERBO, Ouagadougou, Burkina Faso.

Received: February 16, 2018; Published: April 14, 2018

DOI: 10.31080/ASMI.2018.01.0049

Citation: Mahamoudou Sanou. et al. “Double Speed Transfusion in Burkina Faso: Results of the Elisa 4th Generation Tests Versus Determine™ HIV½ of Blood Donors Presumed to be Seroconverting at National Blood Transfusion Center”. Acta Scientific Microbiology 1.5 (2018).

Abstract

  Conflicting results are often observed at blood donors who used 4th generation Elisa and the Determine™ HIV½ tests. This study aims to assess both techniques and determine the most reliable test for blood transfusion.

  This study was conducted at the National Blood Transfusion Center-Ouagadougou. This was a prospective study with descriptive purpose of the results of the two HIV diagnostic techniques over a period of five months from January 1 to May 31, 2014. It covered a total of 10028 samples of which 30 were discordant. A recall of 30 donors with discordant results to the Determine™ HIV ½ have given 4 positive and 26 negative results. Considering the results of the second Determine™ HIV ½ test, we finally retain the following results.

  Among 10028 samples analyzed, 110 were positive for the 4th generation ELISA. Of these 110 positives, the 3rd generation DETERMINE™ HIV test yielded 80 positives and 30 negatives. Recall of the 30 donors with the discordant results two months later gave 4 positive and 26 negative results to the 3rd generation DETERMINE™ HIV test. The Determine™ 3rd Generation Test gives 0.04% false negative in blood donors. The 4th generation ELISA gives 0.3% false positive in blood donors.

  Considering the results of the second DETERMINE HIV½ 3rd generation test, we do not recommend the use of the DETERMINE™ HIV™ 3rd Generation Test alone for HIV screening in blood donors

Keywords: Evaluation; Determine™ HIV ½, Elisa 4th Generation; Discordant; Seroconversion; Blood Donors

Bibliography

  1. Nagalo MB., et al. “Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis among blood donors in Koudougou (Burkina Faso) in 2009”. Blood Transfusion 9.4 (2011): 419-424.
  2. Allain JP., et al. “Relative safety of first-time volunteer and replacement donors in West Africa”. Transfusion 50.2 (2010): 340-343.
  3. Mandisodza AR., et al. “Demographic and social characteristics of regular donors who sero-converted in Harare”. African Journal of Medicine and Medical Sciences 35 (2006): 113-117.
  4. Owusu-Ofori S., et al. “Fostering repeat donations in Ghana”. Biologicals 38.1 (2010): 47-52.
  5. Zohoun A., et al. “[Risk of HIV-1 or 2 infection associated with transfusion in Benin]”. Bulletin De La Societe De Pathologie Exotique 97 (2004): 261-264.
  6. Orkuma JA., et al. “HIV screening in blood donors: rapid diagnostic test versus enhanced ELISA”. Nigerian Journal of Medicine 23.3 (2014): 192-200.
  7. Nagalo BM., et al. “Seroprevalence and incidence of transfusion-transmitted infectious diseases among blood donors from regional blood transfusion centres in Burkina Faso, West Africa”. Tropical Medicine and International Health 17.2 (2012): 247-253.
  8. Essomba NE., et al. “Prevalence of cytomegalovirus in blood donors of a urban district hospital in Douala-Cameroon”. Health Sciences and Diseases 16.2 (2015): 1-5.
  9. Coste J. “[Screening for viral genomes in blood transfusion]”. Transfusion Clinique et Biologique 7.1 (2000): 11s-17s.
  10. Malhotra S., et al. “Seroprevalence of human immunodeficiency virus in north Indian blood donors using third and fourth generation Enzyme linked immunosorbent assay”. Asian Journal of Transfusion Science 7.2 (2013): 125-129.
  11. Delaugerre C., et al. “HIV-1 group N: travelling beyond Cameroon”. Lancet 378.9806 (2011): 1894.
  12. Basavaraju SV., et al. “Reduced risk of transfusion-transmitted HIV in Kenya through centrally co-ordinated blood centres, stringent donor selection and effective p24 antigenHIV antibody screening”. Vox Sang 99.3 (2010): 212-219.
  13. Nebie K., et al. “[Role of quality control for improvement of blood components in the Regional Blood Centre of Ouagadougou in Burkina Faso, 2014]”. Transfusion Clinique et Biologique 24.4 (2017): 431-439.

Copyright: © 2018 Mahamoudou Sanou., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Member In






News and Events

  • Submission Timeline
    Last date for submission of articles is April 10, 2019.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Papers of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US